Overall, sensitivity for identifying chemotherapy administration in the Medicare database has ranged from 88 to 93 depending on cancer type, 32 indicating a need for improvement <a href=http://stromectol.one>stromectol manufacturer</a> 422f Menopause and Breast Cancer